Xingcheng Yi
Overview
Explore the profile of Xingcheng Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang X, Xu W, Zhou F, Huang W, Yi X, Zhang Y, et al.
Am J Cancer Res
. 2025 Mar;
15(2):501-516.
PMID: 40084363
1q gain/amplification (1q+) is the most common cytogenetic abnormality (CA), with a frequency of 30-50% in patients with newly diagnosed multiple myeloma (NDMM). Although accumulating evidence supports 1q+ as a...
2.
Mu R, Li Y, Cui Y, Feng C, Li T, Liu T, et al.
J Ginseng Res
. 2025 Mar;
49(2):145-155.
PMID: 40061487
Aim: Ginsenosides have notable bioactivity in treating cardiovascular diseases, but the mechanisms of their combined use with Peroxiredoxin 6 (PRDX6) in myocardial injury remain unclear. This study explores the synergistic...
3.
Zhang Y, Wang L, Yi X, Ma X, Wu H, Zhang M, et al.
Int J Surg
. 2025 Jan;
111(2):2072-2088.
PMID: 39784532
Background: Growth hormone-secreting pituitary adenomas (GHPA) display diverse biological behaviors and clinical outcomes, necessitating the identification of tumor heterogeneity and prognostically relevant markers. Methods: In this study, we performed single-cell...
4.
Wang L, Yi X, Zhou Y, Gongga L, Yu S, Guo X, et al.
Sci Rep
. 2024 Nov;
14(1):26909.
PMID: 39505982
High altitude is characterized by low oxygen, low pressure, and high radiation. When migrates from low to high altitudes, the body's tissues and organs experience hypoxic stress and will present...
5.
Xu W, Liang X, Liu S, Yi X, Tian M, Yue T, et al.
Clin Med (Lond)
. 2024 Oct;
24(6):100252.
PMID: 39362336
Background: Minimal residual disease (MRD) testing is a promising approach to tailor the treatment of multiple myeloma (MM). However, several major concerns remain to be addressed before moving it into...
6.
Zhang Y, Liang X, Xu W, Yi X, Hu R, Ma X, et al.
J Hematol Oncol
. 2024 Jun;
17(1):48.
PMID: 38915117
It remains a substantial challenge to balance treatment efficacy and toxicity in geriatric patients with multiple myeloma (MM), primarily due to the dynamic nature of frailty. Here, we conducted a...
7.
Teng S, Wang B, Yang F, Yi X, Zhang X, Sun Y
Comput Methods Programs Biomed
. 2024 May;
253:108230.
PMID: 38810377
Background And Objective: The classification of diabetic retinopathy (DR) aims to utilize the implicit information in images for early diagnosis, to prevent and mitigate the further worsening of the condition....
8.
Tian M, Liang X, Xu W, Yi X, Yue T, Zhang Y, et al.
Ann Hematol
. 2023 Jul;
102(10):2943-2945.
PMID: 37434095
No abstract available.
9.
Liu J, Yang N, Yi X, Wang G, Wang C, Lin H, et al.
Food Funct
. 2023 Feb;
14(5):2416-2431.
PMID: 36786409
Increasing studies have demonstrated that ginsenoside Rg3 (Rg3) plays an important role in the prevention and treatment of various diseases, including allergic lower airway inflammation such as asthma. To investigate...
10.
Pan X, Yi X, Lan M, Su X, Zhou F, Wu W
Medicine (Baltimore)
. 2023 Jan;
102(4):e32763.
PMID: 36705386
Colorectal cancer is one of the 3 most common cancers worldwide. In this study, a weighted network-based analysis method was proposed to explore the pathological mechanisms and prognostic targets of...